Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes

Journal of Hepatology

Volumn 44, Issue 6, 2006, Pages 1055-1065

  Meng, Fanyin ^a   Yamagiwa, Yoko ^a   Ueno, Yoshiyuki ^b   Patel, Tushar ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Biliary tract tumors; Kinases; Tumorigenesis

Indexed keywords

DACTINOMYCIN; GEMCITABINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; PROTEIN MCL 1; SMALL INTERFERING RNA; MCL1 PROTEIN; PROTEIN BCL 2; TUMOR PROTEIN;

ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CARCINOMA CELL; CELL ANCHORAGE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; GENE CONSTRUCT; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; BILE DUCT TUMOR; CELL CULTURE; DRUG ANTAGONISM; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; GENETICS; INTRAHEPATIC BILE DUCT; METABOLISM; PATHOLOGY; TRANSACTIVATION; UPREGULATION;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL SURVIVAL; CHOLANGIOCARCINOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTERLEUKIN-6; MICE; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFORMATION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33746902024     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.10.030     Document Type: Article

References (51)

1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33 (2001) 1353-1357
2. Patel T. Worldwide trends in mortality from biliary tract malignancies. Biomed central Cancer 2 (2002) 10
3. Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., and Thomas H.C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37 (2002) 806-813
4. Taylor-Robinson S.D., Toledano M.B., Arora S., Keegan T.J., Hargreaves S., Beck A., et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48 (2001) 816-820
5. Gores G.J. Cholangiocarcinoma: current concepts and insights. Hepatology 37 (2003) 961-969
6. Rosen H.R., Winkle P.J., Kendall B.J., and Diehl D.L. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 42 (1997) 1290-1294
7. Akiyama T., Hasegawa T., Sejima T., Sahara H., Seto K., Saito H., et al. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology 45 (1998) 665-671
8. Kimura F., Miyazaki M., Suwa T., Sugiura T., Shinoda T., Itoh H., et al. Serum interleukin-6 levels in patients with biliary obstruction. Hepatogastroenterology 46 (1999) 1613-1617
9. Scotte M., Daveau M., Hiron M., Delers F., Lemeland J.F., Teniere P., et al. Interleukin-6 (IL-6) and acute-phase proteins in rats with biliary sepsis. Eur Cytokine Netw 2 (1991) 177-182
10. Matsumoto K., Fujii H., Michalopoulos G., Fung J.J., and Demetris A.J. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 20 (1994) 376-382
11. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16 (1998) 249-284
12. Park J., Gores G.J., and Patel T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase. Hepatology 29 (1999) 1037-1043
13. Kallen K.J. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 1592 (2002) 323-343
14. Maione D., Di Carlo E., Li W., Musiani P., Modesti A., Peters M., et al. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. Eur Mol Biol Org J 17 (1998) 5588-5597
15. Goydos J.S., Brumfield A.M., Frezza E., Booth A., Lotze M.T., and Carty S.E. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg 227 (1998) 398-404
16. Yokomuro S., Tsuji H., Lunz III J.G., Sakamoto T., Ezure T., Murase N., et al. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32 (2000) 26-35
17. Sugawara H., Yasoshima M., Katayanagi K., Kono N., Watanabe Y., Harada K., et al. Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology 33 (1998) 145-153
18. Yokomuro S., Lunz III J.G., Sakamoto T., Ezure T., Murase N., and Demetris A.J. The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro. Cytokine 12 (2000) 727-730
19. Sakamoto T., Liu Z., Murase N., Ezure T., Yokomuro S., Poli V., et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29 (1999) 403-411
20. Yamagiwa Y., Marienfeld C., Meng F., Holcik M., and Patel T. Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival. Cancer Res 64 (2004) 1293-1298
21. Park J., Tadlock L., Gores G.J., and Patel T. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology 30 (1999) 1128-1133
22. Patel T. Dysregulation of cholangiocyte apoptosis by cytokines. In: Paumgartner G. (Ed). Diseases of the liver and bile ducts. New aspects and clinical implications (1998), Kluwer Academic Publishers, Lancaster, England
23. Okada K., Shimizu Y., Nambu S., Higuchi K., and Watanabe A. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol 9 (1994) 462-467
24. Yamagiwa Y., Marienfeld C., Tadlock L., and Patel T. Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth. Hepatology 38 (2003) 158-166
25. Tadlock L., Yamagiwa Y., Hawker J., Marienfeld C., and Patel T. Transforming growth factor-{beta} inhibition of proteasomal activity. A potential mechanism of growth arrest. Am J Physiol Cell Physiol 285 (2003) C277-C285
26. Tadlock L., and Patel T. Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line. Hepatology 33 (2001) 43-51
27. Tadlock L., Yamagiwa Y., Marienfeld C., and Patel T. Double-stranded RNA activates a p38 MAPK-dependent cell survival program in biliary epithelia. Am J Physiol Gastrointest Liver Physiol 284 (2003) G924-G932
28. Pramanik R., Qi X., Borowicz S., Choubey D., Schultz R.M., Han J., et al. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem 278 (2003) 4831-4839
29. Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., et al. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem 272 (1997) 30122-30128
30. Han J., Lee J.D., Jiang Y., Li Z., Feng L., and Ulevitch R.J. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271 (1996) 2886-2891
31. Jiang Y., Chen C., Li Z., Guo W., Gegner J.A., Lin S., et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 271 (1996) 17920-17926
32. Kirkin V., Joos S., and Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644 (2004) 229-249
33. Cory S., Huang D.C., and Adams J.M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22 (2003) 8590-8607
34. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80 (1992) 879-886
35. Taniai M., Grambihler A., Higuchi H., Werneburg N., Bronk S.F., Farrugia D.J., et al. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res 64 (2004) 3517-3524
36. Yoon J.H., Werneburg N.W., Higuchi H., Canbay A.E., Kaufmann S.H., Akgul C., et al. Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. Cancer Res 62 (2002) 6500-6505
37. Kobayashi S., Werneburg N.W., Bronk S.F., Kaufmann S.H., and Gores G.J. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 128 (2005) 2054-2065
38. Jourdan M., Veyrune J.L., Vos J.D., Redal N., Couderc G., and Klein B. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Oncogene 22 (2003) 2950-2959
39. Wei L.H., Kuo M.L., Chen C.A., Chou C.H., Cheng W.F., Chang M.C., et al. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene 20 (2001) 5799-5809
40. Lin M.T., Juan C.Y., Chang K.J., Chen W.J., and Kuo M.L. IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1. Carcinogenesis 22 (2001) 1947-1953
41. Jee S.H., Chiu H.C., Tsai T.F., Tsai W.L., Liao Y.H., Chu C.Y., et al. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. J Invest Dermatol 119 (2002) 1121-1127
42. Kietzmann T., Samoylenko A., and Immenschuh S. Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes. J Biol Chem 278 (2003) 17927-17936
43. Jee S.H., Shen S.C., Chiu H.C., Tsai W.L., and Kuo M.L. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene 20 (2001) 198-208
44. Steiner H., Godoy-Tundidor S., Rogatsch H., Berger A.P., Fuchs D., Comuzzi B., et al. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Am J Pathol 162 (2003) 655-663
45. Leu C.M., Wong F.H., Chang C., Huang S.F., and Hu C.P. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 22 (2003) 7809-7818
46. Yang T., Buchan H.L., Townsend K.J., and Craig R.W. MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 166 (1996) 523-536
47. Zhou P., Qian L., Bieszczad C.K., Noelle R., Binder M., Levy N.B., et al. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 92 (1998) 3226-3239
48. Chao J.R., Wang J.M., Lee S.F., Peng H.W., Lin Y.H., Chou C.H., et al. mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol Cell Biol 18 (1998) 4883-4898
49. Wang J.M., Chao J.R., Chen W., Kuo M.L., Yen J.J., and Yang-Yen H.F. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 19 (1999) 6195-6206
50. Schubert K.M., and Duronio V. Distinct roles for extracellular-signal-regulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mcl-1 synthesis. Biochem J 356 (2001) 473-480
51. Kuo M.L., Chuang S.E., Lin M.T., and Yang S.Y. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 20 (2001) 677-685